{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:57:25Z","timestamp":1791215845785,"version":"4.1.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30DK092926"],"award-info":[{"award-number":["P30DK092926"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Diab Rep"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>This systematic examination quantifies financial toxicity- the economic burden and related financial distress experienced by patients due to medical costs- in diabetes management globally, analyzing prevalence, mechanisms, and interventions across diverse healthcare systems and geographic contexts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>Data indicates 30\u201360% of diabetes patients experience financial toxicity, with household expenditures ranging from 5 to 40% of income on disease management, and demographic disparities evident. Current intervention strategies demonstrate limited efficacy, particularly in resource-constrained settings, while policy approaches show mixed results across economic contexts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Financial toxicity operates through four identified pathways: direct expenses, indirect costs (productivity\/caregiver burden), insurance coverage limitations, and structural access barriers. Research priorities include developing validated measurement instruments for diabetes financial toxicity, implementing contextually appropriate interventions, and establishing causative relationships between financial burden and clinical outcomes through longitudinal studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11892-025-01588-0","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T02:42:14Z","timestamp":1747104134000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Financial Toxicity in Diabetes: The State of What We Know"],"prefix":"10.1007","volume":"25","author":[{"given":"Minal R.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"issue":"2","key":"1588_CR1","first-page":"80","volume":"27","author":"SY Zafar","year":"2013","unstructured":"Zafar SY, Abernethy AP. Financial toxicity, part I: a new name for a growing problem. Oncol (Williston Park). 2013;27(2):80\u20131.","journal-title":"Oncol (Williston Park)"},{"issue":"2","key":"1588_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.4037\/ajcc2025476","volume":"34","author":"DG Dotolo","year":"2025","unstructured":"Dotolo DG, Pytel CC, Nielsen EL, Uyeda AM, Im J, Engelberg RA, et al. Time to talk money?? Intensive care unit clinicians\u2019 perspectives on addressing patients\u2019 financial hardship. Am J Crit Care. 2025;34(2):137\u201344.","journal-title":"Am J Crit Care"},{"issue":"1","key":"1588_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12875-025-02738-9","volume":"26","author":"J Larkin","year":"2025","unstructured":"Larkin J, Foley L, Timmons S, Hickey T, Clyne B, Harrington P, et al. How do people with Multimorbidity prioritise healthcare when faced with tighter financial constraints? A National survey with a choice experiment component. BMC Prim Care. 2025;26(1):57.","journal-title":"BMC Prim Care"},{"issue":"1","key":"1588_CR4","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.4102\/phcfm.v15i1.3889","volume":"15","author":"M Kishindo","year":"2023","unstructured":"Kishindo M, Dahlui M, Said MA, Andale T, Mwaura GW, Limo O, et al. Are outpatient costs for hypertension and diabetes care affordable? Evidence from Western Kenya. Afr J Prim Health Care Fam Med. 2023;15(1):e1\u20139.","journal-title":"Afr J Prim Health Care Fam Med"},{"issue":"5","key":"1588_CR5","doi-asserted-by":"publisher","first-page":"daae114","DOI":"10.1093\/heapro\/daae114","volume":"39","author":"A Odunyemi","year":"2024","unstructured":"Odunyemi A, Islam MT, Alam K. The financial burden of noncommunicable diseases from out-of-pocket expenditure in sub-Saharan Africa: a scoping review. Health Promot Int. 2024;39(5):daae114.","journal-title":"Health Promot Int"},{"key":"1588_CR6","unstructured":"International Diabetes Federation. IDF Diabetes Atlas [Internet]. Brussels, Belgium: International Diabetes Federation; 2023 [cited 2025 Mar 2]. Available from: https:\/\/idf.org\/about-diabetes\/diabetes-facts-figures\/"},{"issue":"15","key":"1588_CR7","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1056\/NEJMp1211514","volume":"367","author":"B Obama","year":"2012","unstructured":"Obama B. Securing the future of American health care. N Engl J Med. 2012;367(15):1377\u201381.","journal-title":"N Engl J Med"},{"key":"1588_CR8","unstructured":"Cox C, Amin K, Claxton G. Emergency Department Visits Exceed Affordability Thresholds for Many Consumers with Private Insurance [Internet]. San Francisco: Kaiser Family Foundation; 2022 Sep 16 [cited 2025 Mar 2]. Available from: https:\/\/www.healthsystemtracker.org\/brief\/emergency-department-visits-exceed-affordability-thresholds-for-many-consumers-with-private-insurance\/"},{"issue":"5","key":"1588_CR9","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/hcs2.65","volume":"2","author":"M Nanda","year":"2023","unstructured":"Nanda M, Sharma R. Financial burden of seeking diabetes mellitus care in India: evidence from a nationally representative sample survey. Health Care Sci. 2023;2(5):291\u2013305.","journal-title":"Health Care Sci"},{"issue":"1","key":"1588_CR10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13561-024-00531-5","volume":"14","author":"BA Owusu","year":"2024","unstructured":"Owusu BA, Barnes NA, Doku DT. The National health insurance policy provides little to no benefit to young persons living with type 1 diabetes (T1D)\u2019: a qualitative study of T1D management cost-burden in Southern Ghana. Health Econ Rev. 2024;14(1):74.","journal-title":"Health Econ Rev"},{"issue":"12","key":"1588_CR11","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.2337\/dc21-0740","volume":"44","author":"A Dehn-Hindenberg","year":"2021","unstructured":"Dehn-Hindenberg A, Sa\u00dfmann H, Berndt V, Biester T, Heidtmann B, Jorch N, et al. Long-term occupational consequences for families of children with type 1 diabetes: the mothers take the burden. Diabetes Care. 2021;44(12):2656\u201363.","journal-title":"Diabetes Care"},{"issue":"5","key":"1588_CR12","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1200\/JOP.2013.001322","volume":"10","author":"KM Fenn","year":"2014","unstructured":"Fenn KM, Evans SB, McCorkle R, DiGiovanna MP, Pusztai L, Sanft T, et al. Impact of financial burden of cancer on survivors\u2019 quality of life. J Oncol Pract. 2014;10(5):332\u20138.","journal-title":"J Oncol Pract"},{"key":"1588_CR13","unstructured":"National Cancer Institute. Financial Toxicity and Cancer Treatment (PDQ\u00ae)\u2013Patient Version [Internet]. Bethesda, MD, National Cancer Institute.: 2019 Feb 28 [updated 2023; cited 2025 Mar 2]. Available from: https:\/\/www.cancer.gov\/about-cancer\/managing-care\/track-care-costs\/financial-toxicity-pdq"},{"issue":"3","key":"1588_CR14","first-page":"2273","volume":"30","author":"SL Lueckmann","year":"2022","unstructured":"Lueckmann SL, Schumann N, Kowalski C, Richter M. Identifying missing links in the conceptualization of financial toxicity: a qualitative study. Support Care Cancer. 2022;30(3):2273\u201382.","journal-title":"Support Care Cancer"},{"issue":"4","key":"1588_CR15","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1093\/eurpub\/ckz073","volume":"30","author":"D Vandenberghe","year":"2020","unstructured":"Vandenberghe D, Albrecht J. The financial burden of non-communicable diseases in the European union: a systematic review. Eur J Public Health. 2020;30(4):833\u20139.","journal-title":"Eur J Public Health"},{"issue":"11","key":"1588_CR16","doi-asserted-by":"publisher","first-page":"e0277424","DOI":"10.1371\/journal.pone.0277424","volume":"17","author":"N Abdel-Rahman","year":"2022","unstructured":"Abdel-Rahman N, Manor O, Valinsky L, Mosenzon O, Calderon-Margalit R, Roberman S. What is important for people with type 2 diabetes? A focus group study to identify relevant aspects for Patient-Reported outcome measures in diabetes care. PLoS ONE. 2022;17(11):e0277424.","journal-title":"PLoS ONE"},{"key":"1588_CR17","doi-asserted-by":"publisher","first-page":"1328444","DOI":"10.3389\/fcdhc.2024.1328444","volume":"5","author":"K Wentzell","year":"2024","unstructured":"Wentzell K, Nagel KE. Financial stress in emerging adults with type 1 diabetes: a mini review integrating lessons from cancer research. Front Clin Diabetes Healthc. 2024;5:1328444.","journal-title":"Front Clin Diabetes Healthc"},{"issue":"1","key":"1588_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3122\/jabfm.2022.220272R2","volume":"36","author":"YC Chiang","year":"2023","unstructured":"Chiang YC, Ni W, Zhang G, Shi X, Patel MR. The association between Cost-Related Non-Adherence behaviors and diabetes outcomes. J Am Board Fam Med. 2023;36(1):15\u201324.","journal-title":"J Am Board Fam Med"},{"issue":"3","key":"1588_CR19","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1016\/j.sapharm.2021.04.016","volume":"18","author":"NH Kim","year":"2022","unstructured":"Kim NH, Look KA, Dague L, Winn AN. Financial burden and medication adherence among near-poor older adults in a pharmaceutical assistance program. Res Social Adm Pharm. 2022;18(3):2517\u201323.","journal-title":"Res Social Adm Pharm"},{"key":"1588_CR20","doi-asserted-by":"publisher","first-page":"102246","DOI":"10.1016\/j.pmedr.2023.102246","volume":"34","author":"MR Patel","year":"2023","unstructured":"Patel MR, Anthony Tolentino D, Smith A, Heisler M. Economic burden, financial stress, and cost-related coping among people with uncontrolled diabetes in the U.S. Prev Med Rep. 2023;34:102246.","journal-title":"Prev Med Rep"},{"issue":"1","key":"1588_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.pcd.2021.10.004","volume":"16","author":"MR Patel","year":"2022","unstructured":"Patel MR, Zhang G, Leung C, Song PXK, Heisler M, Choe HM, et al. Impacts of the COVID-19 pandemic on unmet social needs, self-care, and outcomes among people with diabetes and poor glycemic control. Prim Care Diabetes. 2022;16(1):57\u201364.","journal-title":"Prim Care Diabetes"},{"issue":"4","key":"1588_CR22","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2337\/cd21-0004","volume":"39","author":"JR Herges","year":"2021","unstructured":"Herges JR, Neumiller JJ, McCoy RG. Easing the financial burden of diabetes management: A guide for patients and primary care clinicians. Clin Diabetes. 2021;39(4):427\u201336.","journal-title":"Clin Diabetes"},{"issue":"11","key":"1588_CR23","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.2337\/dc22-0494","volume":"45","author":"MR Patel","year":"2022","unstructured":"Patel MR, Zhang G, Heisler M, Song PXK, Piette JD, Shi X, et al. Measurement and validation of the comprehensive score for financial toxicity (COST) in a population with diabetes. Diabetes Care. 2022;45(11):2535\u201343.","journal-title":"Diabetes Care"},{"issue":"1","key":"1588_CR24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s41687-024-00834-5","volume":"9","author":"MR Patel","year":"2025","unstructured":"Patel MR, Troost JP, Heisler M, Carlozzi NE. Clinically meaningful classes of financial toxicity for patients with diabetes. J Patient Rep Outcomes. 2025;9(1):2.","journal-title":"J Patient Rep Outcomes"},{"key":"1588_CR25","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.2147\/DMSO.S263571","volume":"13","author":"B Piroozi","year":"2020","unstructured":"Piroozi B, Mohamadi-Bolbanabad A, Moradi G, Safari H, Ghafoori S, Zarezade Y, et al. Incidence and intensity of catastrophic Health-care expenditure for type 2 diabetes mellitus care in Iran: determinants and inequality. Diabetes Metab Syndr Obes. 2020;13:2865\u201376.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"7","key":"1588_CR26","doi-asserted-by":"publisher","first-page":"103089","DOI":"10.1016\/j.dsx.2024.103089","volume":"18","author":"S Rawat","year":"2024","unstructured":"Rawat S, Bansal N, Yadav R, Goyal S, Nagpal J. Out-of-pocket direct cost of ambulatory care of type 2 diabetes in Delhi: estimates from the Delhi diabetes community-II (DEDICOM-II) survey. Diabetes Metab Syndr. 2024;18(7):103089.","journal-title":"Diabetes Metab Syndr"},{"issue":"4","key":"1588_CR27","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s13340-022-00589-8","volume":"13","author":"L Rohilla","year":"2022","unstructured":"Rohilla L, Gujjar N, Kaur G, Walia P, Dayal D. Financial burden for families of children with type 1 diabetes: a cross-sectional survey from North India. Diabetol Int. 2022;13(4):665\u201371.","journal-title":"Diabetol Int"},{"issue":"1","key":"1588_CR28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1297\/cpe.2024-0071","volume":"34","author":"M Faizi","year":"2025","unstructured":"Faizi M, La ZT, Puteri HA, Waladhiyaputri V, Amalia G, Tjahjono HA, et al. Understanding the burden faced by families of children living with type 1 diabetes mellitus in Indonesia: A multidimensional study on the financial, social, and psychosocial aspects. Clin Pediatr Endocrinol. 2025;34(1):45\u201353.","journal-title":"Clin Pediatr Endocrinol"},{"issue":"7","key":"1588_CR29","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.clinthera.2021.05.008","volume":"43","author":"K Julian","year":"2021","unstructured":"Julian K, Ba DM, Liu G, Leslie DL, Chuang CH. Out-of-Pocket costs of insulin and diabetes-Related supplies among patients with type 1 diabetes. Clin Ther. 2021;43(7):1272\u20137.","journal-title":"Clin Ther"},{"issue":"1","key":"1588_CR30","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1186\/s12913-024-11935-8","volume":"24","author":"SA Mohammed","year":"2024","unstructured":"Mohammed SA, Mengesha HY, Andualem A, Seid E, Assefa GM. Availability, price, and affordability of diabetes mellitus and thyroid dysfunction medicines in South Wollo zone, Northeast Ethiopia. BMC Health Serv Res. 2024;24(1):1434.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"1588_CR31","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12939-022-01791-5","volume":"21","author":"L Zarei","year":"2022","unstructured":"Zarei L, Moradi N, Peiravian F, Hatami-Mazinani N, Mahi-Birjand M, Arabloo J, et al. Catastrophic pharmaceutical expenditure in patients with type 2 diabetes in Iran. Int J Equity Health. 2022;21(1):188.","journal-title":"Int J Equity Health"},{"issue":"1","key":"1588_CR32","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12939-023-01923-5","volume":"22","author":"R Oyando","year":"2023","unstructured":"Oyando R, Were V, Koros H, Mugo R, Kamano J, Etyang A, et al. Evaluating the effectiveness of the National health insurance fund in providing financial protection to households with hypertension and diabetes patients in Kenya. Int J Equity Health. 2023;22(1):107.","journal-title":"Int J Equity Health"},{"issue":"4","key":"1588_CR33","doi-asserted-by":"publisher","first-page":"e14552","DOI":"10.1111\/iwj.14552","volume":"21","author":"H Seshadri","year":"2024","unstructured":"Seshadri H, Karthikeyan V, Rudrakumar M, Seshadri P, Vasudevan D, Ranganathan V, et al. Out-of-pocket expenditure among patients with diabetic foot ulcer in a tertiary care hospital of South India: A cross-sectional study. Int Wound J. 2024;21(4):e14552.","journal-title":"Int Wound J"},{"issue":"1","key":"1588_CR34","doi-asserted-by":"publisher","first-page":"bvae210","DOI":"10.1210\/jendso\/bvae210","volume":"9","author":"RB Conway","year":"2024","unstructured":"Conway RB, Snell-Bergeon J, Honda-Kohmo K, Peddi AK, Isa SB, Sulong S, et al. Disparities in diabetes technology uptake in youth and young adults with type 1 diabetes: A global perspective. J Endocr Soc. 2024;9(1):bvae210.","journal-title":"J Endocr Soc"},{"key":"1588_CR35","doi-asserted-by":"crossref","unstructured":"Fauzi M, Fadiana G, Nadira D, Angela A, Puteri HA, Pulungan A. Pediatric type 1 diabetes care in Indonesia: A review of current challenges and practice. J Clin Res Pediatr Endocrinol. 2024 Nov 27.","DOI":"10.4274\/jcrpe.galenos.2024.2024-9-4"},{"key":"1588_CR36","doi-asserted-by":"publisher","first-page":"117863292413046","DOI":"10.1177\/11786329241304618","volume":"17","author":"B Ruscitti","year":"2024","unstructured":"Ruscitti B, Kern C, Bowser D. Out-of-Pocket costs burden in marketplace plans for people with diabetes. Health Serv Insights. 2024;17:11786329241304618.","journal-title":"Health Serv Insights"},{"issue":"3","key":"1588_CR37","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/1753-0407.13360","volume":"15","author":"Y Lin","year":"2023","unstructured":"Lin Y, Shao H, Fonseca V, Shi L. Exacerbation of financial burden of insulin and overall glucose-lowing medications among uninsured population with diabetes. J Diabetes. 2023;15(3):215\u201323.","journal-title":"J Diabetes"},{"issue":"7","key":"1588_CR38","doi-asserted-by":"publisher","first-page":"e2420724","DOI":"10.1001\/jamanetworkopen.2024.20724","volume":"7","author":"D Barthold","year":"2024","unstructured":"Barthold D, Li J, Basu A. Patient Out-of-Pocket costs for type 2 diabetes medications when aging into medicare. JAMA Netw Open. 2024;7(7):e2420724.","journal-title":"JAMA Netw Open"},{"issue":"8","key":"1588_CR39","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1007\/s11606-021-06937-9","volume":"37","author":"C Rastas","year":"2022","unstructured":"Rastas C, Bunker D, Gampa V, Gaudet J, Karimi S, Majidi A, et al. Association between high deductible health plans and Cost-Related Non-adherence to medications among Americans with diabetes: an observational study. J Gen Intern Med. 2022;37(8):1910\u20136.","journal-title":"J Gen Intern Med"},{"issue":"12","key":"1588_CR40","doi-asserted-by":"publisher","first-page":"e0294164","DOI":"10.1371\/journal.pone.0294164","volume":"18","author":"HJ Warraich","year":"2023","unstructured":"Warraich HJ, Siddiqi HK, Li DG, van Meijgaard J, Vaduganathan M. Pharmacy and neighborhood-level variation in cash price of diabetes medications in the united States. PLoS ONE. 2023;18(12):e0294164.","journal-title":"PLoS ONE"},{"key":"1588_CR41","doi-asserted-by":"publisher","first-page":"101957","DOI":"10.1016\/j.pmedr.2022.101957","volume":"29","author":"CW Leung","year":"2022","unstructured":"Leung CW, Heisler M, Patel MR. Multiple social risk factors are adversely associated with diabetes management and psychosocial outcomes among adults with diabetes. Prev Med Rep. 2022;29:101957.","journal-title":"Prev Med Rep"},{"issue":"3","key":"1588_CR42","doi-asserted-by":"publisher","first-page":"107","DOI":"10.37765\/ajmc.2024.89510","volume":"30","author":"J Quach","year":"2024","unstructured":"Quach J, Midlam C, Sell C, Levin-Scherz J. Out-of-pocket costs for diabetes medications in employer-sponsored health insurance plans. Am J Manag Care. 2024;30(3):107\u20138.","journal-title":"Am J Manag Care"},{"issue":"4","key":"1588_CR43","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.sapharm.2024.01.004","volume":"20","author":"W Chi","year":"2024","unstructured":"Chi W, Song J, Yazdanfard S, Daggolu J, Varisco TJ. Why the increase? Examining the rise in prescription medication expenditures in the united States between 2011 and 2020. Res Social Adm Pharm. 2024;20(4):432\u201342.","journal-title":"Res Social Adm Pharm"},{"issue":"1","key":"1588_CR44","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12961-021-00732-y","volume":"19","author":"J Kazibwe","year":"2021","unstructured":"Kazibwe J, Tran PB, Annerstedt KS. The household financial burden of non-communicable diseases in low- and middle-income countries: a systematic review. Health Res Policy Syst. 2021;19(1):96.","journal-title":"Health Res Policy Syst"},{"issue":"9","key":"1588_CR45","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1007\/s11606-020-06176-4","volume":"36","author":"CJ Herrick","year":"2021","unstructured":"Herrick CJ, Humble S, Hollar L, Chang SH, Hunleth J, McQueen A, et al. Cost-Related medication Non-adherence, cost coping behaviors, and cost conversations among individuals with and without diabetes. J Gen Intern Med. 2021;36(9):2867\u20139.","journal-title":"J Gen Intern Med"},{"issue":"18","key":"1588_CR46","first-page":"1826","volume":"12","author":"MS Arshad","year":"2024","unstructured":"Arshad MS, Alqahtani F, Rasool MF. The economic burden of type 2 diabetes mellitus in Pakistan: A cost of illness study. Healthc (Basel). 2024;12(18):1826.","journal-title":"Healthc (Basel)"},{"issue":"1","key":"1588_CR47","doi-asserted-by":"publisher","first-page":"124","DOI":"10.21315\/mjms2024.31.1.11","volume":"31","author":"N Isamail","year":"2024","unstructured":"Isamail N, Said R, Ismail NW, Haron SA. Non-Communicable diseases impact Low-Income households in Malaysia. Malays J Med Sci. 2024;31(1):124\u201339.","journal-title":"Malays J Med Sci"},{"issue":"9","key":"1588_CR48","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.3390\/ijerph21091250","volume":"21","author":"LAI Trindade","year":"2024","unstructured":"Trindade LAI, Pereira JL, Leite JMRS, Rogero MM, Fisberg RM, Sarti FM. Lifestyle and cardiometabolic risk factors associated with impoverishment due to Out-of-Pocket health expenditure in S\u00e3o Paulo City, Brazil. Int J Environ Res Public Health. 2024;21(9):1250.","journal-title":"Int J Environ Res Public Health"},{"key":"1588_CR49","doi-asserted-by":"publisher","first-page":"1441591","DOI":"10.3389\/fendo.2024.1441591","volume":"15","author":"H Taimur","year":"2024","unstructured":"Taimur H, Ahmad I, Khan H, Shirayama Y, Okamoto M, Aung MN, et al. A scoping review of type 2 diabetes mellitus in Pakistan investigating the status of glycemic control, awareness, treatment adherence, complications and cost. Front Endocrinol (Lausanne). 2024;15:1441591.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1588_CR50","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1001\/jamapediatrics.2020.1065","volume":"175","author":"KP Chua","year":"2021","unstructured":"Chua KP, Lee JM, Conti RM. Potential change in insulin Out-of-Pocket spending under Cost-Sharing caps among pediatric patients with type 1 diabetes. JAMA Pediatr. 2021;175(1):90\u20132.","journal-title":"JAMA Pediatr"},{"issue":"1","key":"1588_CR51","doi-asserted-by":"publisher","first-page":"e14152","DOI":"10.1111\/1475-6773.14152","volume":"59","author":"C McAdam-Marx","year":"2024","unstructured":"McAdam-Marx C, Ruiz-Negron N, Sullivan JM, Tucker JM. The effects of patient out-of-pocket costs on insulin use among people with type 1 and type 2 diabetes with medicare advantage insurance-2014-2018. Health Serv Res. 2024;59(1):e14152.","journal-title":"Health Serv Res"},{"key":"1588_CR52","doi-asserted-by":"crossref","unstructured":"Schrier E, Himmelstein DU, Gaffney A, McCormick D, Woolhandler S. Taxpayers\u2019 Share of US Prescription Drug and Insulin Costs: a Cross-Sectional Study. J Gen Intern Med. 2024 Oct 24.","DOI":"10.1007\/s11606-024-09032-x"},{"issue":"1","key":"1588_CR53","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/1753-0407.13344","volume":"15","author":"AE Wilcox","year":"2023","unstructured":"Wilcox AE, Lipska KJ, Weinzimer SA, Gujral J, Arakaki A, Kerandi L, et al. Navigating barriers to affording and obtaining insulin and diabetes supplies. J Diabetes. 2023;15(1):71\u20135.","journal-title":"J Diabetes"},{"issue":"2","key":"1588_CR54","doi-asserted-by":"publisher","first-page":"238146832312169","DOI":"10.1177\/23814683231216938","volume":"8","author":"PK Dahal","year":"2023","unstructured":"Dahal PK, Rawal L, Ademi Z, Mahumud RA, Paudel G, Vandelanotte C. Estimating the health care expenditure to manage and care for type 2 diabetes in Nepal: A patient perspective. MDM Policy Pract. 2023;8(2):23814683231216938.","journal-title":"MDM Policy Pract"},{"issue":"11","key":"1588_CR55","doi-asserted-by":"publisher","first-page":"e0002538","DOI":"10.1371\/journal.pgph.0002538","volume":"3","author":"R Jaber Chehayeb","year":"2023","unstructured":"Jaber Chehayeb R, Kala S, Abou Ghannam H, Hasan G, Salloum J. The evolving Lebanese drug crisis: trends in drug availability and affordability for common outpatient diseases from 2019 to 2023. PLOS Glob Public Health. 2023;3(11):e0002538.","journal-title":"PLOS Glob Public Health"},{"key":"1588_CR56","doi-asserted-by":"publisher","first-page":"1111565","DOI":"10.3389\/fendo.2023.1111565","volume":"14","author":"M Lin","year":"2023","unstructured":"Lin M, Chen T, Fan G. Current status and influential factors associated with adherence to self-monitoring of blood glucose with type 2 diabetes mellitus patients in grassroots communities: a cross-sectional survey based on information-motivation-behavior skills model in China. Front Endocrinol (Lausanne). 2023;14:1111565.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1588_CR57","doi-asserted-by":"publisher","first-page":"824545","DOI":"10.3389\/fendo.2022.824545","volume":"13","author":"A Phrommintikul","year":"2022","unstructured":"Phrommintikul A, Dilokthornsakul P, Permsuwan U. Economic burdens for treatment of patients with type 2 diabetes in North Thailand: A Hospital-Based observational study. Front Endocrinol (Lausanne). 2022;13:824545.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1588_CR58","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12882-021-02373-3","volume":"22","author":"TR Corwin","year":"2021","unstructured":"Corwin TR, Ozieh MN, Garacci E, Palatnik A, Egede LE. The relationship between financial hardship and incident diabetic kidney disease in older US adults - a longitudinal study. BMC Nephrol. 2021;22(1):167.","journal-title":"BMC Nephrol"},{"issue":"1","key":"1588_CR59","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1186\/s12886-024-03665-6","volume":"24","author":"M Benhamza","year":"2024","unstructured":"Benhamza M, Dahlui M, Said MA. Determining direct, indirect healthcare and social costs for diabetic retinopathy management: a systematic review. BMC Ophthalmol. 2024;24(1):424.","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"1588_CR60","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13047-023-00688-y","volume":"16","author":"N Frescos","year":"2023","unstructured":"Frescos N, Stopher L, Jansen S, Kaminski MR. The financial burden of diabetes-related foot disease in Australia: a systematic review. J Foot Ankle Res. 2023;16(1):92.","journal-title":"J Foot Ankle Res"},{"key":"1588_CR61","doi-asserted-by":"crossref","unstructured":"Hashmi M, Shiraliyeva N, Herrera A, Tabassum H, Schechter C, Daily JP et al. Who\u2019s really footing the bill? Sex and ethnicity disparities in the cost of diabetic foot ulcer-related amputations in a major healthcare system. J Foot Ankle Surg. 2025 Feb 1.","DOI":"10.1053\/j.jfas.2025.01.017"},{"issue":"1","key":"1588_CR62","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s40200-023-01319-w","volume":"23","author":"P Goswami","year":"2023","unstructured":"Goswami P, Anand A. Impact of diabetes on healthcare utilization and expenditure among older adults in India. J Diabetes Metab Disord. 2023;23(1):593\u2013601.","journal-title":"J Diabetes Metab Disord"},{"issue":"8","key":"1588_CR63","first-page":"e66427","volume":"16","author":"A Marwi","year":"2024","unstructured":"Marwi A, Bali IA, Almurashi A, Alharbi EH, Alnkhli IJ, Moneer Alqerafi N. The social and financial burden on families of type 1 diabetic pediatric patients in Madinah region, Saudi Arabia. Cureus. 2024;16(8):e66427.","journal-title":"Cureus"},{"issue":"7","key":"1588_CR64","first-page":"e63588","volume":"16","author":"K DeWitt","year":"2024","unstructured":"DeWitt K, Bjornstad P, Bergmann KR. Health equity considerations for children with type 1 diabetes who utilize insulin Cost-Sharing cap programs. Cureus. 2024;16(7):e63588.","journal-title":"Cureus"},{"issue":"4","key":"1588_CR65","doi-asserted-by":"publisher","first-page":"439","DOI":"10.7326\/M23-1965","volume":"177","author":"LF Garabedian","year":"2024","unstructured":"Garabedian LF, Zhang F, Costa R, Argetsinger S, Ross-Degnan D, Wharam JF. Association of state insulin Out-of-Pocket caps with insulin Cost-Sharing and use among commercially insured patients with diabetes: A Pre-Post study with a control group. Ann Intern Med. 2024;177(4):439\u201348.","journal-title":"Ann Intern Med"},{"issue":"8","key":"1588_CR66","doi-asserted-by":"publisher","first-page":"e2425280","DOI":"10.1001\/jamanetworkopen.2024.25280","volume":"7","author":"TV Giannouchos","year":"2024","unstructured":"Giannouchos TV, Ukert B, Buchmueller T. Health outcome changes in individuals with type 1 diabetes after a State-Level insulin copayment cap. JAMA Netw Open. 2024;7(8):e2425280.","journal-title":"JAMA Netw Open"},{"issue":"8","key":"1588_CR67","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1377\/hlthaff.2024.00118","volume":"43","author":"KE Anderson","year":"2024","unstructured":"Anderson KE, Chaiyakunapruk N, Gutierrez EJ, Schmutz HW, Rose MR, Brixner D, et al. State Out-Of-Pocket caps on insulin costs: no significant increase in claims or utilization. Health Aff (Millwood). 2024;43(8):1137\u201346.","journal-title":"Health Aff (Millwood)"},{"issue":"7","key":"1588_CR68","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3390\/ijerph21070936","volume":"21","author":"A McQueen","year":"2024","unstructured":"McQueen A, von Nordheim D, Caburnay C, Li L, Herrick C, Grimes L, et al. A randomized controlled trial testing the effects of a social needs navigation intervention on health outcomes and healthcare utilization among medicaid members with type 2 diabetes. Int J Environ Res Public Health. 2024;21(7):936.","journal-title":"Int J Environ Res Public Health"},{"issue":"13","key":"1588_CR69","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1007\/s11606-024-08708-8","volume":"39","author":"MR Patel","year":"2024","unstructured":"Patel MR, Zhang G, Heisler M, Piette JD, Resnicow K, Choe HM, et al. A randomized controlled trial to improve unmet social needs and clinical outcomes among adults with diabetes. J Gen Intern Med. 2024;39(13):2415\u201324.","journal-title":"J Gen Intern Med"}],"container-title":["Current Diabetes Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-025-01588-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11892-025-01588-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11892-025-01588-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T13:04:42Z","timestamp":1770296682000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11892-025-01588-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1588"],"URL":"https:\/\/doi.org\/10.1007\/s11892-025-01588-0","relation":{},"ISSN":["1534-4827","1539-0829"],"issn-type":[{"value":"1534-4827","type":"print"},{"value":"1539-0829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,13]]},"assertion":[{"value":"29 April 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human\/Animal Studies Informed Consent Statement"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"32"}}